Ann: Change of Director's Interest Notice - R Highnam, page-27

I see you expect to see more selling, hence you currently don't hold.
Good work if you sold above $2. You are riding a major smack down. $1.40 would be a good price to average down for those that failed to get out.

Failure to get density measures in FDA legislation will see further falls. Management need more sales. Cash burn is horrendous, hence the 23% smack down in recent days.

So many promises in Oct19 and zero delivered in Nov19. These microcaps are not for the faint hearted.